您好,欢迎来到上海士研管理咨询有限公司
产业峰会 演讲局 专家智库服务 峰会活动服务 整合营销服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 演讲局:
    致力于为全球企业和机构提供主题演讲家、高管大师班、董事会顾问,每项服务都提供了一种更深入、更具互动性的体验,尤其是针对较小的精选受众和关键个人。我们拥有最具影响力的商业领袖和顶级专家的资源,他们是各自领域的最杰出的代表。我们的团队由经验丰富的演讲和活动经理组成,我们注重建立长期而深入的伙伴关系。
  • 专家智库服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布二十多个行业,而且每天还在增加!
  • 峰会活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,包括调研策划、定制邀请、营销推广、运营组织、项目管理、直播与数字化会议等,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 整合营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
嘉宾信息
发布时间: 2021 - 06 - 03
点击次数: 0
所属职位: 副总裁
所属公司: 上海东富龙科技股份有限公司
个人简介:
郑金旺,高级工程师,上海东富龙科技股份有限公司副总裁;国家药品监督管理局高级研修学院特聘专家,ISPE中国2015-2016会员发展委员会主席,中国医药设备工程协会专家,中国制药装备行业协会专家委员会专家,中国药学会制药工程专业委员会委员,全国制药装备标准化技术委员会委员,全国制药工程专业学位研究生教育协助组工程领域专家,上海现代制药装备系统工程技术研究中心主任,上海医药行业协会新技术、新技能专业委员会委员,浙江省药品检查中心职业检查“双百尖兵”外聘专家。 20多年无菌原料药、无菌注射剂行业经验,曾经多次到欧、美、日制药生产企业及制药设备制造企业进行技术交流,在无菌注射剂和无菌原料药核心区域生产线工艺设计、风险控制、工艺设备和厂房设施的确认与验证、系统自控、项目管理等方面具有丰富的经验。作为讲师,多次参与国家药品监督管理局审核查验中心、高研院、各省市药监局认证中心和安监处、各行业协会等组织举办的技术交流和培训。
发布时间: 2021 - 06 - 03
点击次数: 0
所属职位: 副总裁
所属公司: 上海创诺医药集团有限公司
个人简介:
安晓霞,教授级高级工程师,上海创诺医药集团有限公司副总裁,负责集团国内制剂业务,带领公司致力于科技创新和产业化推进,特别在艾滋病药物、抗肿瘤药物的创新和产业化方面作出重要贡献。Mrs An, vice-president of Shanghai Acebright Pharmaceuticals Group Co.,Ltd., responsible for the FDF R & D business, leading the company to commit to technological innovation and industrialization, especially in the anti-HIV drugs and anti-tumor drugs.Mrs An, vice-president of Shanghai Acebright Pharmaceuticals Group Co.,Ltd., responsible for the FDF R & D business, leading the company to commit to technological innovation and industrialization, especially in the anti-HIV drugs and anti-tumor drugs.
发布时间: 2021 - 06 - 03
点击次数: 0
所属职位: 创始人
所属公司: 上海汇像信息技术有限公司
个人简介:
刘家朋,上海交通大学模式识别与智能系统专业博士,上海汇像信息技术有限公司创始人,长期以来一直从事机器人与机器视觉、人工智能与大数据的应用研究与开发。曾负责和参与SGS,BV,INTERTEK,TUV,华测,广电,深圳计量质检院等多家第三方机构及政府监管机构的自动化智能化系统建设,在食品安全检测自动化,纺织品安全检测自动化,重金属安全检测自动化,微生物细菌病毒检测自动化以及核酸检测自动化等拥有丰富的项目开发与设计经验。Jiapeng Liu, Ph.D. in Pattern Recognition and Intelligent System from Shanghai Jiaotong University, founder of Shanghai X-imaging Information Technology Co., Ltd., has been engaged in the application research and development of robots and machine vision, artificial intelligence and big data for a long time. He was responsible for and participated in the construction of automated and intelligent systems for SGS, BV, INTERTEK, TUV, CTI, GRGTEST, SMQ and other third-party agencies and government regulatory agencies. In food safety inspection automation, textile safety inspection automation.He has rich project development and design experience in food safety testing automation, textile safety testing automation, heavy metal safety testing automation, microbial, bacteria and virus testing automation, and nucleic acid testing automation.
发布时间: 2021 - 06 - 03
点击次数: 0
所属职位: 武田中国总裁
所属公司: 武田(中国)投资有限公司
个人简介:
单国洪先生于2017年9月18日起出任武田中国总裁,常驻上海,全面负责武田中国(包括香港、澳门地区)的整体战略及业务增长,同时也是武田成长与新兴市场管理层委员。在他的领导下,武田中国成功实现了战略转型,近年来业务高速发展,中国市场已成为武田全球最重要的战略市场之一。单国洪先生拥有逾二十年以上行业管理经验,对中国的医疗及制药行业有着独到的洞察和深刻的认知。在加入武田之前,他曾出任辉瑞创新集团中国区总经理、阿斯利康中国区副总裁等跨国药企高级管理职位;同时还曾担任辉瑞全球肿瘤委员会,阿斯利康全球呼吸领域品牌委员会成员等职务。凭借其丰富的国际化管理经验以及深刻的行业洞察力,他曾成功地领导了肿瘤、免疫、罕见病及疫苗等多个疾病领域的创新产品在中国大陆、香港及澳门地区的获批与上市,使这些创新药品更早惠及中国患者。作为一名医疗行业资深专业人士,单国洪先生活跃于各项社会事务,并担任多个社会职务。他是中国癌症基金会和中国医药生物技术协会的常务理事,中国外商投资企业协会药品研制和开发行业委员会(RDPAC)执行委员会委员,也是复旦大学管理学院的校友导师,并拥有美国华盛顿大学和复旦大学高级工商管理硕士(EMBA)学位。  Sean Shan has been appointed as President of Takeda China since 18 September 2017, taking full responsibilities for Takeda’s overall strategy and business development in China, including Hong Kong and Macao. In addition to his role as China head, he also sits on the Leadership Committee of Growth & Emerging Markets of Takeda, representing China market. Under his leadership Takeda China has accelerated its strategic transformation with great success recently. The businesses keep a fast pace with strong growth across broad therapeutic areas. China now is seen one of the most important strategic markets at Takeda worldwide.  Bringing his over 20 years’ experiences in pharmaceutical industry in China, Sean is a seasoned executive with versatile functional expertise in marketing and sales, business development. Before joining Takeda, he took several roles as senior executive in the leading MNCs, such as General Manager of Innovation Healthcare of Pfizer China, Vice President of Astra Zeneca China etc. Apart from his country leadership role, he also held global key positions as the member of Global Oncology Council of Pfizer, Global Respiratory Brand Council of Astra Zeneca. Combining his international leadership experience and in-depth functional expertise in pharmaceutical industry, he has been leading several new drugs approval and launch across mainland China, Hong Kong and Macao, with specific to oncology, immunology, rare disease and vaccine. More Chinese patients are benefitting now from these innovative medicines.  As a senior healthcare professional Sean has been proactively taking social responsibilities and roles. He is now a standing member of the board of China Cancer Foundation and China Medical and Biotechnological Association, executive committee member of RDPAC, and alumina tutor of Management School of Fudan University. He possesses EMBA from University of Washington and Fudan University. Sean and his family are based in Shanghai.
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务